clinical trial · NCT06776679
A Study of How [14C]-BGB-16673 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Participants
BeiGene·phase1·completed·n = 8
Healthy Volunteers[14C]-BGB-16673
brief summary
The purpose of this study is to determine the absorption, metabolism, and excretion of \[14C\]-BGB-16673 and to characterize and determine, where possible, the metabolites present in plasma, urine, and feces in healthy male participants following a single oral administration.
started
Jan 24, 2025
primary completion
Mar 27, 2025
completion
Mar 27, 2025
last updated
May 1, 2025
official title
A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-BGB-16673 Following a Single Oral Dose in Healthy Male Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol